Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: comparison with a long-acting calcium channel antagonist, amlodipine.
D000368:Aged; D000450:Aldosterone / Q000097:blood; D017311:Amlodipine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D047228:Angiotensin II Type 1 Receptor Blockers; D002121:Calcium Channel Blockers / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003327:Coronary Disease / Q000150:complications; D003692:Delayed-Action Preparations; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood; D018377:Neurotransmitter Agents / Q000097:blood / Q000502:physiology*; D009638:Norepinephrine / Q000097:blood; D044140:Receptor, Angiotensin, Type 1 / Q000502:physiology*; D013777:Tetrazoles / Q000493:pharmacokinetics*; D013997:Time Factors; D014633:Valine / Q000031:analogs & derivatives / Q000493:pharmacokinetics*; D000068756:Valsartan
D047228:Angiotensin II Type 1 Receptor Blockers; D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D018377:Neurotransmitter Agents; D044140:Receptor, Angiotensin, Type 1; D013777:Tetrazoles; D020097:Natriuretic Peptide, Brain; D017311:Amlodipine; D000450:Aldosterone; D000068756:Valsartan; D014633:Valine; D009638:Norepinephrine